TickerFacts.

A business in context

ABUS research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-10-22 · 8029 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 4 · Ownership change

    Report date 2026-10-01 · 0001447028-26-000061

  2. 4 · Ownership change

    Report date 2026-10-01 · 0001447028-26-000060

  3. 4 · Ownership change

    Report date 2026-10-01 · 0001447028-26-000059

  4. 4 · Ownership change

    Report date 2026-10-01 · 0001447028-26-000058

  5. 4 · Ownership change

    Report date 2026-10-01 · 0001140361-26-038692

  6. 4 · Ownership change

    Report date 2026-09-18 · 0001447028-26-000053

  7. 4 · Ownership change

    Report date 2026-09-18 · 0001447028-26-000052

  8. 4 · Ownership change

    Report date 2026-09-18 · 0001447028-26-000051

  9. 8-K · Current report

    Report date 2026-08-21 · 0001104659-26-099390 · Items 8.01,9.01

  10. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001447028-26-000045

  11. 8-K · Current report

    Report date 2026-08-12 · 0001171843-26-005442 · Items 2.02,9.01

  12. 8-K · Current report

    Report date 2026-07-15 · 0001171843-26-004708 · Items 1.02,5.02,8.01,9.01

  13. 8-K · Current report

    Report date 2026-05-26 · 0001447028-26-000024 · Items 5.02,5.07,9.01

  14. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001447028-26-000021

  15. 8-K · Current report

    Report date 2026-05-13 · 0001171843-26-003346 · Items 2.02,9.01

  16. 8-K · Current report

    Report date 2026-04-14 · 0001171843-26-002458 · Items 8.01,9.01

  17. DEF 14A · Proxy statement

    Report date 2026-05-26 · 0001140361-26-014623

  18. 10-K · Annual report

    Report date 2025-12-31 · 0001447028-26-000017

  19. 8-K · Current report

    Report date 2026-03-23 · 0001171843-26-001838 · Items 2.02,9.01

  20. 8-K · Current report

    Report date 2026-03-03 · 0001171843-26-001299 · Items 1.01,8.01,9.01

  21. 8-K · Current report

    Report date 2026-02-17 · 0001171843-26-000979 · Items 8.01,9.01

  22. 8-K · Current report

    Report date 2026-02-02 · 0001171843-26-000676 · Items 8.01,9.01

  23. 8-K · Current report

    Report date 2026-01-15 · 0001171843-26-000303 · Items 8.01,9.01

  24. 8-K · Current report

    Report date 2025-12-11 · 0001171843-25-007879 · Items 8.01,9.01

  25. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001447028-25-000126

  26. 8-K · Current report

    Report date 2025-11-13 · 0001171843-25-007256 · Items 2.02,8.01,9.01

  27. 8-K · Current report

    Report date 2025-10-07 · 0001171843-25-006316 · Items 8.01,9.01

  28. 8-K · Current report

    Report date 2025-09-09 · 0001171843-25-005815 · Items 8.01,9.01

  29. 10-Q · Quarterly report

    Report date 2025-06-30 · 0001447028-25-000115

  30. 8-K · Current report

    Report date 2025-08-04 · 0001171843-25-005076 · Items 2.02,5.02,8.01,9.01

  31. 8-K · Current report

    Report date 2025-06-20 · 0001171843-25-004094 · Items 1.02,8.01,9.01

  32. 8-K · Current report

    Report date 2025-05-21 · 0001447028-25-000104 · Items 5.07

  33. 10-Q · Quarterly report

    Report date 2025-03-31 · 0001447028-25-000099

  34. 8-K · Current report

    Report date 2025-05-14 · 0001171843-25-003153 · Items 2.02,9.01

  35. 8-K · Current report

    Report date 2025-05-07 · 0001171843-25-002841 · Items 8.01,9.01

  36. 8-K · Current report

    Report date 2025-04-23 · 0001171843-25-002401 · Items 8.01,9.01

  37. DEF 14A · Proxy statement

    Report date 2025-05-21 · 0001140361-25-012305

  38. 8-K · Current report

    Report date 2025-03-28 · 0001447028-25-000093 · Items 5.02,8.01

  39. 10-K · Annual report

    Report date 2024-12-31 · 0001447028-25-000083

  40. 8-K · Current report

    Report date 2025-03-27 · 0001171843-25-001760 · Items 2.02,9.01

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-10-15 · 2026 Q3: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 0 transaction rows0AExercise / conversion: 16 transaction rows16MTax / exercise payment: 4 transaction rows4FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

20 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-09-18
2026-09-23
Androski LindsayM · Exercise / conversion
Acquired
Common Shares116408.03.2
2026-09-18
2026-09-23
Androski LindsayF · Tax / exercise payment
Disposed
Common Shares82527.05.07
2026-09-18
2026-09-23
Androski LindsayM · Exercise / conversion
Acquired
Common Shares10456.04.39
2026-09-18
2026-09-23
Androski LindsayM · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
10456.00.0
2026-09-18
2026-09-23
Androski LindsayM · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
116408.00.0
2026-09-18
2026-09-23
Nguyen TuanM · Exercise / conversion
Acquired
Common Shares265625.03.49
2026-09-18
2026-09-23
Nguyen TuanF · Tax / exercise payment
Disposed
Common Shares206637.05.07
2026-09-18
2026-09-23
Nguyen TuanM · Exercise / conversion
Acquired
Common Shares27475.04.39
2026-09-18
2026-09-23
Nguyen TuanM · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
27475.00.0
2026-09-18
2026-09-23
Nguyen TuanM · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
265625.00.0
2026-09-18
2026-09-23
Sawhney RogerF · Tax / exercise payment
Disposed
Common Shares100508.05.07
2026-09-18
2026-09-23
Sawhney RogerM · Exercise / conversion
Acquired
Common Shares78800.04.24
2026-09-18
2026-09-23
Sawhney RogerM · Exercise / conversion
Acquired
Common Shares52533.03.34
2026-09-18
2026-09-23
Sawhney RogerM · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
52533.00.0
2026-09-18
2026-09-23
Sawhney RogerM · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
78800.00.0
2026-09-18
2026-09-23
Beardsley Robert AF · Tax / exercise payment
Disposed
Common Shares99057.05.07
2026-09-18
2026-09-23
Beardsley Robert AM · Exercise / conversion
Acquired
Common Shares52533.03.2
2026-09-18
2026-09-23
Beardsley Robert AM · Exercise / conversion
Acquired
Common Shares78800.04.24
2026-09-18
2026-09-23
Beardsley Robert AM · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
52533.00.0
2026-09-18
2026-09-23
Beardsley Robert AM · Exercise / conversion
Disposed
Stock Option (Right to Buy)
Derivative security
78800.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-10-15 · 1663 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001447028Arbutus Biopharma Corp

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-10-15 · 1199 checked identities; 0 unavailable records

Search names and former names

View Wikidata identity and references ↗

  • Arbutus Biopharma · alias · wikidata
  • Tekmira Pharmaceuticals · alias · wikidata
  • TEKMIRA PHARMACEUTICALS CORP · former SEC name · 2011-06-08 to 2015-08-03
  • TEKMIRA PHARMACEUTICALS Corp · former SEC name · 2011-06-08 to 2015-08-03
Explore headquarters map ↗

Revenue in constant purchasing power

USD revenue expressed in 2026-09 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

Year endedReported USD revenueCPI-adjusted USD revenue
2024-12-31$6.17M$6.63M
2023-12-31$18.14M$20.06M
2022-12-31$39.02M$44.92M
2021-12-31$10.99M$13.66M
2020-12-31$6.91M$9.00M
2019-12-31$6.01M$7.92M
2018-12-31$5.95M$7.98M
2017-12-31$10.70M$14.71M

Bureau of Labor Statistics · retrieved 2026-10-22 · 9 selected series; gaps remain missing

Explore the CPI history ↗